CRA International vs ICF International
CRAI and ICFI side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CRAI and ICFI compare
CRA International and ICF International are about the same size, with market caps of $1.3B and $1.4B.
On earnings, ICF International is cheaper: it trades at 16.1× trailing earnings, against 27.9× for CRA International.
CRA International grew revenue faster over the last twelve months (11.5% versus −7.9% for ICF International).
CRA International keeps more of each dollar of sales as profit, with a net margin of 6.2% compared with 4.9% at ICF International.
Both pay dividends: CRA International yields 1.1% and ICF International 0.72%.
ICF International scores higher on the StockData Score (20 against 12 for CRA International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CRAI | ICFI |
|---|---|---|
| Size and price | ||
| Market cap | $1.3B | $1.4B |
| Share price | $209.66 | $78.00 |
| Change, 1 year | 15.9% | −0.06% |
| Change, 5 years | 116% | −22.2% |
| Beta (5Y) | −0.11 | 1.44 |
| Employees | 597 | 8,400 |
| StockData Score | ||
| Total score | 12 | 20 (better) |
| Valuation score | 0 | 6 (better) |
| Growth score | 2 | 2 |
| Performance score | 5 (better) | 4 |
| Health score | 2 | 4 (better) |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | 27.9× | 16.1× (better) |
| P/S | 1.7× | 0.8× (better) |
| P/B | 7.2× | 1.3× (better) |
| EV/EBITDA | 13.9× | 9.1× (better) |
| P/FCF | – | 7.0× |
| PEG | 2.48 | 1.19 (better) |
| FCF yield | −2.1% | 14.2% (better) |
| Fair value | $160.82 | $118.69 |
| Margin of safety | −30.4% | 34.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 11.5% (better) | −7.9% |
| Revenue growth, 5Y average | 8.1% (better) | 4.4% |
| Net income growth (TTM) | −12.8% (better) | −17.8% |
| EPS growth (TTM) | −9.1% (better) | −16.0% |
| EPS growth, 5Y average | 21.5% (better) | 11.5% |
| Profitability | ||
| Gross margin | 29.0% | 37.2% (better) |
| Operating margin | 10.0% (better) | 7.8% |
| Net margin | 6.2% (better) | 4.9% |
| FCF margin | −3.5% | 10.9% (better) |
| Return on equity | 26.0% (better) | 8.6% |
| Return on invested capital | 32.0% (better) | 7.7% |
| Financial health | ||
| Debt / equity | – | 0.39 |
| Net debt / EBITDA | – | 2.05 |
| Interest coverage | 11.2× (better) | 4.9× |
| Current ratio | 0.82 | 1.39 (better) |
| Altman Z-score | 3.41 (better) | 2.65 |
| Piotroski F-score | 7 | 7 |
| Dividends and buybacks | ||
| Dividend yield | 1.1% (better) | 0.72% |
| Payout ratio | 29.2% | 11.6% |
| Years of dividend growth | 9 (better) | 0 |
| Dividend growth, 5Y average | 16.5% (better) | 0.00% |
| Buyback yield | 4.1% (better) | 3.3% |
| Shareholder yield | 5.1% (better) | 4.0% |
| Ownership | ||
| Held by institutions | 94.8% | 102% |
| Held by insiders | 3.7% | 1.8% |
| Insider net buying, 12 months | −$6.2M | −$1.4M (better) |
| Short interest, % of float | 5.0% | 3.6% |
Go deeper
- CRAI stock overview
- CRAI income statement
- CRAI valuation and score
- ICFI stock overview
- ICFI income statement
- ICFI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.